By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Chugai Pharmaceutical Co., Ltd. (Japan) 

1-9, Kyobashi 2-chome

Chuo-ku  Tokyo  104-8301  Japan
Phone: 81-3-3281-6611 Fax: 81-3-3281-2828


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





Company News
Chugai Pharmaceutical Co., Ltd. (Japan) Licenses ISPRI/Optimatrix Platform From EpiVax, Inc. For De-Risking Biologics 10/30/2014 9:27:40 AM
Disappointment Looms As Roche (RHHBY) Drops Plans To Bid For The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) 8/26/2014 6:00:53 AM
Conflicting Reports Surface Over Roche Holding AG (RHHBF.PK)'s $10 Billion Deal, Chugai Pharmaceutical Co., Ltd. (Japan) Denies Talks 8/18/2014 5:54:39 AM
Roche (RHHBY) May Gobble Up The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) For $10 Billion 8/15/2014 10:51:33 AM
Helsinn Group And Marketing Enter Into Agreement For Marketing Rights Of Netupitant-Palonosetron Fixed-Dose Combination (NEPA) In The UK And Ireland And For Palonosetron Monotherapy In The UK 7/17/2014 9:14:54 AM
Chugai Pharmaceutical Co., Ltd. (Japan) Invests $30 Million To Build China Marketing/Distribution 12/30/2013 1:29:24 PM
Roche (RHHBY) Has No Plan to Sell Chugai Pharmaceutical Co., Ltd. (Japan) Stake 4/12/2013 7:54:53 AM
Chugai Pharmaceutical Co., Ltd. (Japan) and Debiopharm Announce an Exclusive License Agreement for Anti-Cancer Agent, FF284 1/8/2013 10:48:22 AM
Chugai Pharmaceutical Co., Ltd. (Japan) to Invest $150 Million in Singapore 7/17/2012 7:47:47 AM
Chugai Pharmaceutical Co., Ltd. (Japan) Standardizes on Medidata Rave Clinical Technology 1/31/2011 10:52:14 AM
1234567
//-->